NCI opportunity webinar: “Anti-EGFR Antibodies for the Treatment of Human Cancers”
Attend a free NIH webinar, attendees will learn about new antibodies developed in Dr. David Fitzgerald’s Lab that bind a particular structure on the external domain of epidermal growth factor receptor (EGFR) which is displayed on cancer cells that express high EGFR levels or the variant termed ‘EGFRvIII’. Importantly, these antibodies do not bind normal …